MARKET

ICLR

ICLR

ICON plc
NASDAQ
164.85
+1.27
+0.78%
After Hours: 164.85 0 0.00% 19:30 09/04 EDT
OPEN
159.94
PREV CLOSE
163.58
HIGH
165.92
LOW
159.50
VOLUME
796.40K
TURNOVER
--
52 WEEK HIGH
203.91
52 WEEK LOW
66.57
MARKET CAP
12.72B
P/E (TTM)
183.29
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ICLR last week (0824-0828)?
Weekly Report · 08/31 09:07
Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update
Seeking Alpha · 08/27 01:53
ICON (ICLR) Stock May Be 27% Below Fair Value Despite ESG Progress
Simply Wall St · 08/26 22:18
Weekly Report: what happened at ICLR last week (0817-0821)?
Weekly Report · 08/24 09:07
ICON Showcases 2025 ESG and Innovation Gains in Latest ICON Cares Report
TipRanks · 08/20 13:18
ICON (ICLR) Could Be 7% Undervalued On Its $2.15b Refinancing Move
Simply Wall St · 08/20 01:35
ICON plc Raises $2.15 Billion in Senior Notes to Refinance Secured Debt
TipRanks · 08/18 13:49
Weekly Report: what happened at ICLR last week (0810-0814)?
Weekly Report · 08/17 09:07
More
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Webull offers ICON PLC stock information, including NASDAQ: ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.